论文部分内容阅读
卵巢癌常在晚期才被发现。寻找肿瘤标记物常徒劳。在瑞典,近十年卵巢癌的发病率有所增加。目前在妇科恶性肿瘤中卵巢癌的死亡率已居首位。本文研究的目的是分析各种不同因素对卵巢恶性上皮性肿瘤(下称卵巢癌)预后的影响。材料从1974至1978年,瑞典Lund大学医院的肿瘤科妇科组共收治494例卵巢癌病人。并均按FIGO进行临床分期,其中391例(90%)Ⅰ～Ⅲ期的治疗方法如下:Ⅰ_a晚和Ⅰ_b晚的病人(有囊外赘生物或囊壁已破裂者)或Ⅰ_c、Ⅱ、Ⅲ期病人是应用单纯放疗(XRT)或化疗加放疗(M+XRT)。Ⅰ_a早和Ⅰ_b早的病人(无囊外赘生物或囊壁破裂者)是根据组织
Ovarian cancer is often found only in later stages. Looking for tumor markers often vain. In Sweden, the incidence of ovarian cancer has increased in the past decade. Ovarian cancer mortality is currently the highest among gynecological malignancies. The purpose of this study is to analyze the impact of various factors on the prognosis of ovarian malignant epithelial tumors (hereinafter referred to as ovarian cancer). Materials From 1974 to 1978, 494 patients with ovarian cancer underwent oncology and gynecology in Lund University Hospital in Sweden. According to FIGO clinical stage, and 391 cases (90%) Ⅰ ~ Ⅲ of the treatment as follows: Ⅰ_a late and Ⅰ_b late patients (with extracapsular neoplasms or ruptured wall) or Ⅰ_c, Ⅱ, Ⅲ Period patients are treated with radiotherapy alone (XRT) or chemotherapy plus radiotherapy (M + XRT). Ⅰ_a early and early Ⅰ_b patients (no extracapsular neoplasms or rupture of the wall) is based on tissue